Stock Fundamentals

Company Information

Company Name
DiaMedica Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA25253X2077
CIK: 0001401040
CUSIP: 25253X207
Currency: USD
Full Time Employees: 27
Phone: 763 496 5454
Fiscal Year End: December
IPO Date: Jan 04, 2008
Description:

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Address:

301 Carlson Parkway, Minneapolis, MN, United States, 55305

Directors & Officers

Name Title Year Born
Mr. Dietrich John Pauls MBA President, CEO & Director 1971
Mr. Scott Kellen CPA CFO & Corporate Secretary 1965
Dr. Ambarish Shah Ph.D. Chief Technology Officer NA
Mr. Dominic R. Cundari Chief Commercial Officer 1951
Dr. Julie Krop M.D. Chief Medical Officer 1966

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Cooperman Leon G 2.02M Dec 31, 2025 3.88% $0.53 -38.22%
BlackRock Inc 1.68M Sep 30, 2025 3.22% $0.00 40.81%
Millennium Management LLC 1.19M Sep 30, 2025 2.28% $0.00 0.00%
PARAGON Assoc & PARAGON Assoc II JV 875.00K Dec 31, 2025 1.68% $14.39 0.00%
Vanguard Group Inc 723.12K Dec 31, 2025 1.39% $0.00 8.81%
Geode Capital Management, LLC 711.82K Sep 30, 2025 1.37% $0.00 12.96%
Morgan Stanley - Brokerage Accounts 579.59K Sep 30, 2025 1.11% $0.00 141.02%
First Manhattan Co. LLC 505.00K Sep 30, 2025 0.97% $0.01 -16.73%
State Street Corp 476.58K Sep 30, 2025 0.92% $0.00 89.16%
Bleichroeder LP 382.32K Sep 30, 2025 0.73% $0.51 0.00%
Northern Trust Corp 339.58K Sep 30, 2025 0.65% $0.00 4.63%
LPL Financial Corp 203.15K Sep 30, 2025 0.39% $0.00 2.86%
Advisor Group Holdings, Inc. 182.31K Sep 30, 2025 0.35% $0.00 26.35%
CI Private Wealth LLC 140.00K Sep 30, 2025 0.27% $0.00 0.00%
Wellington Management Company LLP 103.70K Dec 31, 2025 0.20% $0.00 0.00%
MEMBERS WEALTH LLC 101.38K Dec 31, 2025 0.19% $0.54 0.00%
CANTOR FITZGERALD, L. P. 100.00K Sep 30, 2025 0.19% $0.01 0.00%
Charles Schwab Investment Management Inc 96.88K Dec 31, 2025 0.19% $0.00 4.82%
The Informed Momentum Company (formerly EAM Investors) 91.43K Dec 31, 2025 0.18% $0.08 0.00%
Fred Alger Management, LLC 83.14K Dec 31, 2025 0.16% $0.00 0.00%

Shares Statistics

Shares Outstanding: 52.08M
Shares Float: 27.33M
% Insiders: 2,866.80%
% Institutions: 3,977.00%
Short % Float: 12.15%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Cooperman Leon G 2.02M 3.88% ▼ 38.22% Dec 31, 2025
2 BlackRock Inc 1.68M 3.22% ▲ 40.81% Sep 30, 2025
3 Millennium Management LLC 1.19M 2.28% ▲ 0.00% Sep 30, 2025
4 PARAGON Assoc & PARAGON Assoc II JV 875.00K 1.68% ▲ 0.00% Dec 31, 2025
5 Vanguard Group Inc 723.12K 1.39% ▲ 8.81% Dec 31, 2025
6 Geode Capital Management, LLC 711.82K 1.37% ▲ 12.96% Sep 30, 2025
7 Morgan Stanley - Brokerage Accounts 579.59K 1.11% ▲ 141.02% Sep 30, 2025
8 First Manhattan Co. LLC 505.00K 0.97% ▼ 16.73% Sep 30, 2025
9 State Street Corp 476.58K 0.92% ▲ 89.16% Sep 30, 2025
10 Bleichroeder LP 382.32K 0.73% ▲ 0.00% Sep 30, 2025

Valuation Metrics

Enterprise Value: $358.44M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $414.02M
EBITDA: $-33.56M
Book Value: $0.99
Earnings/Share: $-0.71
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.33%
ROE (TTM): -64.12%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 8.28x 0.00x 0.12x N/A 0.00x
2023-12-31 19.27x 0.00x 0.06x N/A 0.00x
2022-12-31 15.61x 0.00x 0.07x -39.66x 0.00x
2021-12-31 29.82x 0.00x 0.03x -166.41x 0.00x
2020-12-31 13.77x 0.00x 0.07x -55.45x -0.01x
2019-12-31 6.70x 0.01x 0.16x -97.42x -0.01x
2018-12-31 13.87x 0.00x 0.07x N/A 0.00x
2017-12-31 1.49x 0.00x 0.56x N/A 0.00x
2016-12-31 2.96x 0.16x 0.33x -51.30x -0.09x
2015-12-31 0.20x -0.53x 6.53x -29.79x -0.43x
2014-12-31 0.15x 0.00x 6.43x N/A 0.00x
2013-12-31 1.72x 0.00x 0.52x -960.91x 0.00x
2012-12-31 1.56x 0.00x 0.41x -3,722.19x 0.00x
2011-12-31 7.51x 0.00x 0.06x -533.81x 0.00x
2010-12-31 5.67x 0.00x 0.06x N/A 0.00x
2009-12-31 3.51x 0.00x 0.16x N/A 0.00x
2008-12-31 11.66x 0.00x 0.07x N/A 0.00x
2007-12-31 13.39x 0.00x 0.06x N/A 0.00x
2006-12-31 6.32x 0.00x 0.08x N/A 0.00x
2005-12-31 5.64x 0.00x 0.10x -26.73x 0.00x
2004-12-31 0.02x -0.16x 5.90x -16.49x -0.27x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 25, 2025 Jan Stahlberg N/A Purchase 73.10K $8.57 $626.46K
Nov 24, 2025 Jan Stahlberg N/A Purchase 40.25K $7.89 $317.60K
Nov 21, 2025 Jan Stahlberg N/A Purchase 208.87K $7.41 $1.55M
Nov 20, 2025 Jan Stahlberg N/A Purchase 128.43K $7.41 $951.64K
Nov 19, 2025 Jan Stahlberg N/A Purchase 240.35K $7.21 $1.73M
Nov 18, 2025 Jan Stahlberg N/A Purchase 182.88K $6.75 $1.23M
Nov 17, 2025 Jan Stahlberg N/A Purchase 187.39K $6.52 $1.22M
Aug 27, 2025 Jan Stahlberg N/A Purchase 50.77K $6.00 $304.63K
Aug 26, 2025 Jan Stahlberg N/A Purchase 59.65K $6.00 $357.89K
Aug 25, 2025 Jan Stahlberg N/A Purchase 338.27K $6.00 $2.03M
Aug 22, 2025 Jan Stahlberg N/A Purchase 59.79K $5.96 $356.34K
Aug 21, 2025 Jan Stahlberg N/A Purchase 48.17K $5.96 $287.11K
Aug 20, 2025 Jan Stahlberg N/A Purchase 71.11K $5.86 $416.69K
Aug 15, 2025 Jan Stahlberg N/A Purchase 8.23K $6.00 $49.40K
Aug 14, 2025 Jan Stahlberg N/A Purchase 70.41K $5.99 $421.78K
Aug 13, 2025 Jan Stahlberg N/A Purchase 293.60K $5.91 $1.74M
Jul 23, 2025 Jan Stahlberg N/A Purchase 1.54M $3.50 $5.40M

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DMAC.US!